InvestSMART

Regis Healthcare Limited (ASX:REG)

ALERT: Price-sensitive ASX Announcement for REG
Current share price for REG : $6.170 -2.09 (-25.30%)+
Announcement
Release
25 Aug 2025 8:49AM
Price at Release
$8.260
Full Release
download
Summary
Regis Healthcare Limited announced a strong financial performance for FY25, with a revenue increase of 15% to $1,161.3 million. The company reported an underlying EBITDA growth of 17% and a statutory NPAT rise of 329%, reaching $49 million. Key operational highlights include improved occupancy rates at mature homes, the opening of a new 112-bed facility in Camberwell, and several strategic acquisitions, including Ti Tree and BodeWell. The company has set a growth target of 10,000 beds by FY28, supported by acquisitions and greenfield developments. Regis also emphasized its commitment to high-quality care, supported by increased government funding and workforce enhancements.
Key Points
  • Revenue from services increased by 15% to $1,161.3 million.
  • Statutory NPAT up by 329% to $49 million.
  • Net operating cash flow increased by 21% to $306.1 million.
  • Mature homes average occupancy improved to 95.6%.
  • Acquisition of Ti Tree and BodeWell expanded the service footprint.
  • Opening of a new 112-bed facility in Camberwell.
  • Growth target of 10,000 available beds set for FY28.
  • Significant increase in care minutes per resident per day.
  • Strategic focus on greenfield developments and acquisitions.
  • Regis plans to benefit from new government funding reforms.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.